Clinical Trial Update: The Effects of Conversion From Cyclosporine to Tacrolimus on the Changes of Cardiovascular Risk Profiles and Serum Metabolites in Renal Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating cardiovascular risk profile changes and serum metabolites after conversion from cyclosporine to tacrolimus in kidney transp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Kyungpook National University Hospital | Conditions: CYCLOSPORINE/TACROLIMUS | Phase 4 | Status: UNKNOWN